Related Experiment Video
Updated: Jun 4, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Progress, Pitfalls, and Impact of AI-Driven Clinical Trials
Dominika Wilczok1, Alex Zhavoronkov2,3,4
1Duke University, Durham, North Carolina, USA.
Artificial intelligence (AI) in drug discovery and development (AIDD) has seen major investment but few clinical successes. This perspective analyzes challenges and opportunities for AI to revolutionize pharmaceutical research.
Area of Science:
- Pharmaceutical Sciences
- Computational Biology
- Biotechnology
Background:
- Significant investment has flowed into applying artificial intelligence (AI) to drug discovery and development (AIDD) since the 2010s.
- Despite substantial resources, AI-driven drug candidates have seen limited progression into human clinical trials and no approvals.
Purpose of the Study:
- To critically examine the obstacles hindering the advancement of AI in drug discovery and development.
- To identify and highlight key opportunities for leveraging AI to transform the pharmaceutical R&D landscape.
Main Methods:
- This is a perspective piece, involving a critical analysis of the current state of AI in drug discovery.
- Literature review and expert opinion synthesis on challenges and future directions.
Main Results:
- Progress in AI for drug discovery is impeded by several critical challenges.
- Numerous opportunities exist to enhance AI's impact on the drug discovery and development pipeline.
Conclusions:
- Overcoming current challenges is crucial for realizing the full potential of AI in accelerating the delivery of novel therapeutics.
- Strategic focus on specific opportunities can drive transformative changes in AI-driven drug discovery and development.
More Related Videos
09:00TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
Published on: April 13, 2021
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Current Trends in Nursing II
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blinding
Methods of Documentation III: PIE